CAJ | 학술논문

目的：分析膀胱癌经尿道膀胱肿瘤电切术后患者膀胱灌注化疗期间的症状及其对患者的困扰程度及特点，探讨患者不适症状的个体化干预方法。方法应用自编一般资料调查表、M. D. Anderson症状调查量表及增补条目，对84例膀胱癌术后膀胱灌注化疗患者进行调查分析。个体化干预后观察患者症状的改善情况。结果患者术后膀胱灌注化疗期间的症状分量表平均得分(3.12±1.02)分，属轻度；症状分量表条目得分排序前5位依次是胃口差、疲劳乏力、睡眠不安、恶心、呕吐。困扰分量表平均得分(2.85±2.02)分，属轻度；困扰分量表条目得分从高到低依次为工作、情绪、一般活动、生活乐趣、行走、人际关系。增补条目得分依次是膀胱内烧灼感、膀胱刺激征、胃肠道反应。给予个体化干预后患者部分症状评分明显下降(P<0.05)。结论膀胱癌经尿道膀胱肿瘤电切术后患者膀胱灌注化疗期间普遍存在症状困扰，提示应根据患者症状困扰的特点进行个体化干预，以缓解其症状困扰。
목적：분석방광암경뇨도방광종류전절술후환자방광관주화료기간적증상급기대환자적곤우정도급특점，탐토환자불괄증상적개체화간예방법。방법응용자편일반자료조사표、M. D. Anderson증상조사량표급증보조목，대84례방광암술후방광관주화료환자진행조사분석。개체화간예후관찰환자증상적개선정황。결과환자술후방광관주화료기간적증상분량표평균득분(3.12±1.02)분，속경도；증상분량표조목득분배서전5위의차시위구차、피로핍력、수면불안、악심、구토。곤우분량표평균득분(2.85±2.02)분，속경도；곤우분량표조목득분종고도저의차위공작、정서、일반활동、생활악취、행주、인제관계。증보조목득분의차시방광내소작감、방광자격정、위장도반응。급여개체화간예후환자부분증상평분명현하강(P<0.05)。결론방광암경뇨도방광종류전절술후환자방광관주화료기간보편존재증상곤우，제시응근거환자증상곤우적특점진행개체화간예，이완해기증상곤우。
Objective To discuss the extent and characteristics of symptoms and symptom distress, and find the individualized management for patients undergoing bladder perfusion chemotherapy after transurethral bladder resection of bladder tumor. Methods The general information questionnaire, M. D. Anderson Symptom Inventory ( MDASI) and additional entries were used to investigate 84 patients undergoing bladder perfusion chemotherapy after transurethral bladder resection of bladder tumor. After individualized treatment, scores of symptoms were observed. Results Symptom score of patients in this group was (3. 12 ± 1. 02), which was at the mild level. Symptoms subscale score entries sorted successively as poor appetite, fatigue, disturbed sleep, nausea, and vomiting. Symptom distress score was (2. 85 ± 2. 02), which was at the mild level. Distress subscale score in the order of entries were work, mood and general activity, enjoyment of life, walking and relationship. Added entries score in the order were burning sensation in the bladder, bladder irritation and gastrointestinal reactions. Scores of some symptoms were significantly lower than before ( P < 0. 05 ). Conclusions Symptom distress is prevalent in patients undergoing bladder perfusion chemotherapy after transurethral bladder resection of bladder tumor, prompting that the intervention should be individualized according to the patient′s symptom distress features to alleviate their symptoms distress.